SAFC preparing for inevitable shift to cell culture vaccines
This content item was originally published on www.outsourcing-pharma.com, a William Reed online publication.
Speaking to in-PharmaTechnologist David Backer, director of business development and marketing at SAFC Pharma, said that the level of funds the US government has put into cell culture means it is certain to become mainstream.
Consequently, SAFC is preparing for this shift and equipping itself to provide products and services for next generation vaccines. This will ensure it can meet the changing demands of the seasonal flu market, as well as dealing with pandemics as they occur, and continue growing.
